FEATURE 1. Pfizer*/BioNTech SE* 2. Moderna, Inc.* ON THE HORIZON: 5 PROMISING EXAMPLES OF VACCINES IN VARIOUS STAGES OF CLINICAL TRIALS 11. Curevac & GlaxoSmithKline* (GSK) 3. Janssen Pharmaceuticals, Inc. EUA APPROVED VACCINES OUTSIDE OF THE U.S.: IN USE IN 1 OR MORE COUNTRIES 4. AstraZeneca* 5. Bharat Biotech 6. CanSino Biological Inc. 7. Gamaleya National Center of Epidemiology and Microbiology 8. Federal Budgetary Research Institution State Research Center of Virology and Biotechnology AKA The Vector Institute 9. Sinopharm 10. Sinovac Biotech 12. Inovio Pharmaceuticals, Inc. (Inovio) 13. GSK* & Vir Biotechnology 14. Novavax* 15. Israel Institute for Biological Research (IIBR) CONCLUDING THOUGHTS To ensure the global population reaches herd immunity, much still needs to be researched and addressed moving forward with R&D efforts related to vaccinations and the virus's control. All factors taken separately and together will affect public health's ability to combat the disease. The vaccine race cannot be about who makes the most money or which country can purchase the largest number of vaccines. It cannot be which vaccine gets EUA approval first. Ultimately, what type of vaccine or groups of vaccines collectively will provide the best duration will need to be considered. If we hope to return to a better new normal, we must protect the globe's population. We can do this by working together and using vaccines that are the safest, most effective, permit population access and ultimately lead to herd immunity. [5,54] 14 Lehigh County Health & Medicine | SUMMER 2021